Skip to content

To check efficacy of wundschutzgel in sunburn

An Open Label, Single Arm Clinical Study to Evaluate the healing activity of Wundschutzgel in Sunburn as example of light burns

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/09/045569
Enrollment
59
Registered
2022-09-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T231- Burn of first degree of wrist andhand

Interventions

Intervention1: Wundschutzgel gel: Dose: approx 1ml twice a day route of administration: Topical duration: 5 days Control Intervention1: Not Applicable: Not Applicable

Sponsors

NUTRIN GmbH
Lead Sponsor
Mittal Global Clinical Trial Services
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age from 18 to 65 years 2.If female with childbearing potential, must be willing to practice an acceptable form of birth control for the duration of the study. 3.Subjects that are able to give written informed consent in a manner approved by the institutional ethics committee and comply with the requirements of the study. 4.Subjects willing to avoid participation in any other interventional clinical trial for the duration of the study.

Exclusion criteria

Exclusion criteria: 1.Females that are pregnant, breast feeding, or planning to get pregnant during the study. 2.Patients that have participated in any other interventional clinical trial in the previous 30 days. 3.Patients with known sensitivity to any of the constituents of the investigational product. 4.Any person suffering from heavily bleeding or weeping wound.

Design outcomes

Primary

MeasureTime frame
Reduction in Sunburn measured as change in VAS ScoreTimepoint: Baseline (day 0) and Day 5

Secondary

MeasureTime frame
Change in skin ElasticityTimepoint: Baseline (day 0) and Day 5;Change in skin ErythemaTimepoint: Baseline (day 0) and Day 5;QOL changes to be measured as DLQITimepoint: Baseline (day 0) and Day 5

Countries

India

Contacts

Public ContactPuneet Mittal

Mittal Global Clinical Trial Services

puneetmittal@mgcts.org

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026